MEET QPS AT AD/PD™ 2024; March 5-9, Lisbon, Portugal

Rodent Biobank

QPS Neuropharmacology’s well characterized and validated in vivo rodent models are useful tools to push your CNS drug discovery to the next level. We are happy to support your research activities with sample material from our biobank containing various specimen derived from several in vivo models. Different samples of transgenic and non-transgenic animals of relevant age groups are readily available such as brain tissue, CSF, and plasma samples.

QPS Neuropharmacology holds one of the largest rodent tissue biobanks for neuroscience research. Rodent biobanks are an indispensable tool for pharmaceutical research. They provide valuable resources for scientists studying disease mechanism and biomarkers relevant for their drug development processes, while also reducing the number of animals used in research and minimizing the suffering of animals. Thus, our biobank helps prioritizing animal welfare while advancing pharmaceutical innovations.

Tissue of the following models is readily available:

Alzheimer’s disease and Tauopathies: 5xFAD mice, APPSL mice, APPSLxhQC mice, hTau mice, PS19 mice

Parkinson’s disease: Line 61 mice, LRRK2 rats

Rare diseases: TDP43 mice, NPC1 mice, 4L/PS-NA mice, Pompe 6neo mice, GBA D409V mice, zQ175 mice, Col4A3 mice

Next to standard tissues, model-specific tissues, such as liver of NPC1 mice or kidney of Col4A3 mice, are readily available or upon request.

Special samplings:

If your research requires samples of our models such as special brain regions or organs that are not readily available in our biobank, we can usually provide these tissues upon request.

In addition to tissue samples from rodent models bred at QPS Neuropharmacology, we can sample tissues of any commercially available rodent model, including but not limited to BTBR mice, Fmr1-KO mice, SOD1 mice and rats, SAMP8 mice.

QPS Neuropharmacology routinely induces various diseases in mice and rats, such as the scopolamine model of Alzheimer’s disease, the AAV2 hA53T-α-syn, MPTP and 6-OHDA models of Parkinson’s disease, the CBE model of Gaucher disease, the MK-801, amphetamine and phencyclidine models of schizophrenia, the LPS model of neuroinflammation, the cuprizone and EAE models of multiple sclerosis, the AAV9-hTDP-43 model of amyotrophic lateral sclerosis as well as the CCl4 model of liver fibrosis. Tissues of these models can be sampled upon request.

Can’t find what you are looking for? Contact us to discuss alternative options that fit your needs.

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE